151 related articles for article (PubMed ID: 26885666)
1. Registered report: Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.
Bhargava A; Anant M; Mack H; ;
Elife; 2016 Feb; 5():. PubMed ID: 26885666
[TBL] [Abstract][Full Text] [Related]
2. Registered Report: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Sharma V; Young L; Cavadas M; Owen K;
Elife; 2016 Mar; 5():. PubMed ID: 26999821
[TBL] [Abstract][Full Text] [Related]
3. Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Bhargava A; Pelech S; Woodard B; Kerwin J; Maherali N; ;
Elife; 2016 Feb; 5():. PubMed ID: 26882073
[TBL] [Abstract][Full Text] [Related]
4. Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.
Heidorn SJ; Milagre C; Whittaker S; Nourry A; Niculescu-Duvas I; Dhomen N; Hussain J; Reis-Filho JS; Springer CJ; Pritchard C; Marais R
Cell; 2010 Jan; 140(2):209-21. PubMed ID: 20141835
[TBL] [Abstract][Full Text] [Related]
5. Registered report: Diverse somatic mutation patterns and pathway alterations in human cancers.
Sharma V; Young L; Allison AB; Owen K; ;
Elife; 2016 Feb; 5():. PubMed ID: 26894955
[TBL] [Abstract][Full Text] [Related]
6. Registered report: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.
Lesnik J; Antes T; Kim J; Griner E; Pedro L; ;
Elife; 2016 Jan; 5():e07383. PubMed ID: 26826285
[TBL] [Abstract][Full Text] [Related]
7. Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia.
Fung JJ; Kosaka A; Shan X; Danet-Desnoyers G; Gormally M; Owen K; ;
Elife; 2015 Sep; 4():. PubMed ID: 26327698
[TBL] [Abstract][Full Text] [Related]
8. Registered report: A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.
Haven B; Heilig E; Donham C; Settles M; Vasilevsky N; Owen K; ;
Elife; 2016 Feb; 5():. PubMed ID: 26905833
[TBL] [Abstract][Full Text] [Related]
9. Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.
Khan I; Kerwin J; Owen K; Griner E; ;
Elife; 2015 Sep; 4():. PubMed ID: 26335297
[TBL] [Abstract][Full Text] [Related]
10. Registered report: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment.
Evans J; Essex A; Xin H; Amitai N; Brinton L; Griner E; ;
Elife; 2015 Aug; 4():. PubMed ID: 26287525
[TBL] [Abstract][Full Text] [Related]
11. Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors.
Chatelle CV; Hövermann D; Müller A; Wagner HJ; Weber W; Radziwill G
Sci Rep; 2016 Mar; 6():23713. PubMed ID: 27025703
[TBL] [Abstract][Full Text] [Related]
12. Registered report: Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
Blum D; LaBarge S;
Elife; 2014 Dec; 3():. PubMed ID: 25490933
[TBL] [Abstract][Full Text] [Related]
13. Registered report: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.
Phelps M; Coss C; Wang H; Cook M; ;
Elife; 2016 Mar; 5():. PubMed ID: 26943900
[TBL] [Abstract][Full Text] [Related]
14. Registered report: Systematic identification of genomic markers of drug sensitivity in cancer cells.
Vanden Heuvel JP; Bullenkamp J;
Elife; 2016 Jun; 5():. PubMed ID: 27336789
[TBL] [Abstract][Full Text] [Related]
15. Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.
Repass J; Maherali N; Owen K; ;
Elife; 2016 Feb; 5():. PubMed ID: 26882501
[TBL] [Abstract][Full Text] [Related]
16. Registered report: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis.
Fiering S; Ang LH; Lacoste J; Smith TD; Griner E;
Elife; 2015 Jul; 4():e04796. PubMed ID: 26179155
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 1-(3,3-dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a pan-RAF inhibitor with minimal paradoxical activation and activity against BRAF or RAS mutant tumor cells.
Henry JR; Kaufman MD; Peng SB; Ahn YM; Caldwell TM; Vogeti L; Telikepalli H; Lu WP; Hood MM; Rutkoski TJ; Smith BD; Vogeti S; Miller D; Wise SC; Chun L; Zhang X; Zhang Y; Kays L; Hipskind PA; Wrobleski AD; Lobb KL; Clay JM; Cohen JD; Walgren JL; McCann D; Patel P; Clawson DK; Guo S; Manglicmot D; Groshong C; Logan C; Starling JJ; Flynn DL
J Med Chem; 2015 May; 58(10):4165-79. PubMed ID: 25965804
[TBL] [Abstract][Full Text] [Related]
18. Active Ras induces heterodimerization of cRaf and BRaf.
Weber CK; Slupsky JR; Kalmes HA; Rapp UR
Cancer Res; 2001 May; 61(9):3595-8. PubMed ID: 11325826
[TBL] [Abstract][Full Text] [Related]
19. Registered report: IDH mutation impairs histone demethylation and results in a block to cell differentiation.
Richarson AD; Scott DA; Zagnitko O; Aza-Blanc P; Chang CC; Russler-Germain DA;
Elife; 2016 Mar; 5():e10860. PubMed ID: 26971564
[TBL] [Abstract][Full Text] [Related]
20. Analyses of the oncogenic BRAF
Cope NJ; Novak B; Liu Z; Cavallo M; Gunderwala AY; Connolly M; Wang Z
J Biol Chem; 2020 Feb; 295(8):2407-2420. PubMed ID: 31929109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
